Clinical Trial

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 3, 2024 (before its estimated December 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
This project is designed to test the hypothesis that adalimumab is clinically useful for patients with acuta Vogt-Koyanagi-Harada disease
Protocol Amendment History 1 change
minor Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05590416
Lead Sponsor Tianjin Medical University
Conditions Vogt-Koyanagi-Harada Disease, Adalimumab
Enrollment 15 participants
Start Date 2021-06-01
Primary Completion 2024-12-01 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-03